# Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED

> **NCT04485533** · NA · UNKNOWN · sponsor: **VISUfarma SpA** · enrollment: 90 (estimated)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DEVICE:** VisuXL® Gel
- **DEVICE:** HYLO®

## Key facts

- **NCT ID:** NCT04485533
- **Lead sponsor:** VISUfarma SpA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-06
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-04-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04485533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04485533, "Clinical Investigation to Assess the Efficacy and the Safety of VisuXL® Gel Administered in Patients Affected by Moderate DED". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04485533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*